Abstract:RNA virus infections are detected by the RIG-I family of receptors, which signal through the adaptor molecule mitochondrial antiviral signaling (MAVS). MAVS then recruits the adaptor's tumor necrosis factor receptor-associated factor (TRAF) 3 and TRAF6, which in turn activate IRF3 and NF-kappa B, respectively, to induce interferons (IFNs) and inflammatory responses. Here we show that the biotin-containing enzyme methylcrotonoyl-CoA carboxylase 1 (MCCC1) enhances virus-induced, MAVS-mediated IFN and inflammatory cytokine expression through the NF-kappa B signaling pathway. MCCC1 knockdown strongly inhibits induction of IFNs and inflammatory cytokines. Furthermore, MCCC1 shows extensive antiviral activity toward RNA viruses, including influenza A virus, human enterovirus 71, and vesicular stomatitis virus. Here, we have elucidated the mechanism underlying MCCC1-mediated inhibition of viral replication. MCCC1 interacts with MAVS and components of the MAVS signalosome and contributes to enhanced production of type I IFNs and pro-inflammatory cytokines by promoting phosphorylation of the I kappa B kinase (IKK) complex and NF-kappa B inhibitor-alpha (I kappa B alpha), as well as NF-kappa B nuclear translocation. This process leads to activation of IFNs and cytokine expression and subsequent activation of IFN-stimulated genes, including double-stranded RNA-dependent protein kinase PKR and myxovirus resistance protein 1. These findings demonstrate that MCCC1 plays an essential role in virus-triggered, MAVS-mediated activation of NF-kappa B signaling.

c-Abl tyrosine kinase interacts with MAVS and regulates innate immune response

MAVS O-GlcNAcylation is Essential for Host Antiviral Immunity Against Lethal RNA Viruses.

Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3

PPM1A Silences Cytosolic RNA Sensing and Antiviral Defense Through Direct Dephosphorylation of MAVS and TBK1.

Identification and Characterization of MAVS, a Mitochondrial Antiviral Signaling Protein that Activates NF-κB and IRF3

Autophagy regulates MAVS signaling activation in a phosphorylation-dependent manner in microglia

MicroRNA-33/33* Inhibit the Activation of MAVS Through AMPK in Antiviral Innate Immunity

MAVS Positively Regulates Mitochondrial Integrity and Metabolic Fitness in B Cells

MAVS Regulates Apoptotic Cell Death by Decreasing K48-Linked Ubiquitination of Voltage-Dependent Anion Channel 1

MAVS: A Two-Sided CARD Mediating Antiviral Innate Immune Signaling and Regulating Immune Homeostasis

Negative regulation of MAVS-mediated innate immune response by ASC

Noncanonical MAVS signaling restrains dendritic cell–driven antitumor immunity by inhibiting IL-12

Methylcrotonoyl-CoA carboxylase 1 potentiates RLR-induced NF-κB signaling by targeting MAVS complex

Eef1bγ is a Positive Regulator of NF-кB Signaling Pathway.

Genome-Wide CRISPR/Cas9 Screening Identifies That Mitochondrial Solute Carrier SLC25A23 Attenuates Type I IFN Antiviral Immunity Via Interfering with MAVS Aggregation.

Regulation of MAVS Expression and Signaling Function in the Antiviral Innate Immune Response

Lck/Hck/Fgr-Mediated Tyrosine Phosphorylation Negatively Regulates TBK1 to Restrain Innate Antiviral Responses.

Methylcrotonoyl-Coa Carboxylase 1 Potentiates Rlr-Induced Nf-Kappa B Signaling By Targeting Mavs Complex

NAC1 Potentiates Cellular Antiviral Signaling by Bridging MAVS and TBK1.

Palmitoylation acts as a checkpoint for MAVS aggregation to promote antiviral innate immune responses

Bcl6 Sets a Threshold for Antiviral Signaling by Restraining IRF7 Transcriptional Program